Nuvo Aiming For Fourth Quarter Response To Pennsaid “Approvable” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Already agreed-upon studies should be concluded in time, but FDA could require more animal data for approval of the topical NSAID.